CHM chimeric therapeutics limited

Ann: Completion of retail component of Entitlement Offer, page-2

  1. 5,630 Posts.
    lightbulb Created with Sketch. 9460
    A$4.3m from retail investors, that's a pretty solid outcome when compared to the $7.4m raised from deep pocket instos.

    65% of placement successfully completed already, with Bell Potter looking to place the reamining 35% under the retail offer.

    Looks like CHM will be funded to achieve its goals and no delays or changes in trajectory required due to a shortfall in funding (which is always a risk, as the corporate looks to cut costs to work within the funding constraints).

    A great outcome if they can get the A$18m they asked for, with A$11.7m already in the bag ... A$6.3m to go!

    With funding sorted, the business can focus on execution... and there is a lot to execute this year alone!
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.4¢
Change
0.000(0.00%)
Mkt cap ! $8.060M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 90000 0.5¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 3222028 3
View Market Depth
Last trade - 09.37am 24/06/2025 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.